CytoSorbents Reports Second Quarter 2022 Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street falls as oil rebounds, Middle East tensions simmer
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil up almost 2% as Iran's president vows to never surrender
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Cytosorbents (CTSO) Misses Q2 EPS by 12c
August 2, 2022 5:03 PM EDTCytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.25), $0.12 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.58 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More